Pure Global

M3VAS Validation in Polish Population - Trial NCT06412562

Access comprehensive clinical trial information for NCT06412562 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of Gdansk and is currently Recruiting. The study focuses on Depressive Disorder. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06412562
Recruiting
diagnostic test
Trial Details
ClinicalTrials.gov โ€ข NCT06412562
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
M3VAS Validation in Polish Population
The Maudsley 3-item Visual Analogue Scale (M3VAS) Validation in Polish Population Diagnosed With Major Depressive Episode

Study Focus

Depressive Disorder

The Maudsley 3-item Visual Analogue Scale (M3VAS)

Observational

diagnostic test

Sponsor & Location

Medical University of Gdansk

Gdaล„sk, Poland

Timeline & Enrollment

N/A

May 09, 2024

Sep 01, 2026

150 participants

Primary Outcome

The Maudsley 3-item Visual Analogue Scale (M3VAS)

Summary

Low mood and anhedonia represent the fundamental symptoms of major depressive disorder (MDD).
 Nevertheless, there is currently no standardized visual analogue scale available to assess
 the extent of both symptoms concurrently. The Maudsley 3-item Visual Analogue Scale (M3VAS)
 is a newly developed tool for participants to self-assess core symptoms of depression: mood
 quality, pleasure experience (anhedonia), and suicidality. Despite suicidality not being a
 primary symptom, it is included due to its critical relevance to safety. Participants will be
 instructed to rate the intensity and frequency of their experiences over the preceding two
 weeks by marking a 100 mm ungraded line. A researcher will then assign a numerical value
 based on the mark's position, utilizing the left edge as 0 and the right as 100. The total
 score range, combining the three symptoms, ranged from 0 (minimum) to 300 (maximum). The
 M3VAS exhibited good psychometric properties in British population. In this study, the
 objective is to assess the psychometric properties of the scale within the Polish population
 diagnosed with major depressive episode within major depressive disorder or bipolar disorder.

ICD-10 Classifications

Depressive conduct disorder
Recurrent depressive disorder, unspecified
Recurrent depressive disorder
Other recurrent depressive disorders
Recurrent depressive disorder, currently in remission

Data Source

ClinicalTrials.gov

NCT06412562

Non-Device Trial